8359:TSEHachijuni Nagano Bank, Ltd. Analysis
Data as of 2026-06-13 - not real-time
¥2,342.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock sits on a solid technical foundation: the 20‑day SMA now exceeds both the 50‑day and 200‑day averages, signaling a long‑term bullish trajectory, while the 30‑day volatility sits at a high 51% and the beta of roughly 0.95 places the share in line with the broader market. RSI hovers around the mid‑range (≈54), indicating neither strong over‑bought nor over‑sold pressure, and the MACD shows a bearish histogram with the line crossing below the signal, suggesting a potential short‑term pull‑back. Financial metrics show a PE of 16.6, which is marginally lower than the industry average of 16.8, and a price‑to‑book ratio of 0.92, suggesting the stock is modestly undervalued relative to peers. The dividend yield of 2.8% with a payout ratio under 40% adds a modest income component, while the limited analyst coverage highlighted by the Morningstar report underscores a need for independent assessment.
Overall, the blend of a bullish technical trend, modest undervaluation, and a stable dividend makes the stock attractive for holding, but the high volatility, moderate sector risk, and a forward‑PE projection of over 44 suggest caution in committing to larger positions.
Overall, the blend of a bullish technical trend, modest undervaluation, and a stable dividend makes the stock attractive for holding, but the high volatility, moderate sector risk, and a forward‑PE projection of over 44 suggest caution in committing to larger positions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- 20‑day SMA above 50‑day and 200‑day SMA
- MACD bearish signal indicating possible pull‑back
- Stable volume and modest dividend yield
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- PE slightly below industry average
- High forward‑PE indicating future valuation pressure
- Limited analyst coverage requiring self‑assessment
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Price‑to‑book ratio under 1 suggests intrinsic undervaluation
- Steady dividend yield with low payout ratio
- Geographic concentration in Japan limiting exposure
Key Metrics & Analysis
Financial Health
Revenue Growth177.80%
Profit Margin25.70%
P/E Ratio16.6
ROE6.09%
ROA0.48%
P/B Ratio0.9
Op. Cash Flow¥-281847005184
Industry P/E16.8
Technical Analysis
TrendBullish
RSI54.2
Support¥2,205.00
Resistance¥2,470.50
MA 20¥2,325.00
MA 50¥2,206.48
MA 200¥1,826.44
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Target Price¥2,300.00
Upside/Downside-1.81%
GradeUndervalued
TypeBlend
Dividend Yield2.77%
Risk Assessment
Beta0.95
Volatility51.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.